Good Morning All26 Nov 2018 11:22
Re share price predictions,it is impossible to be accurate or very close to the eventual share price in the event of big Pharma taking over running of Phase 3 for either compound(VAL-201 or 401).However 10p suggested here is far to low in that situation,considering that not so long ago we were at 7p+/share with little change to current position we are in at the moment.Furthermore,should an II get interested in the share,the whole game will change drastically.Some of you have not even been invested here when the share price was at 72p/share not so long after the consolidation and in spite of the dilution since then,we have got only just over 0.5 billion shares in total.For IIs that would be about just right but the most if not all shares are held here by private individuals hence my view is that the share price might reach 20-30p/share on entering Phase 3 for a single drug.I think that VAL-201 has much more Clinical data than VAL-401.Both are used in the final stages of different diseases so the valuation may be similar.I wish ROCHE gets involved here as they usually do not mess about having never being short of cash in their history.I can say now that we shall not wait very long for the news,at the latest beginning of January 2019.GLA - Stach